Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Total Current Liabilities
All obligations due within one year.
Translational Development Acquisition Corp.NASDAQ: TDAC
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 166.7% from a year ago
Total current liabilities stood at $861.09K at the end of Q1 FY2026, up 166.7% from a year earlier and up 58.3% from the prior quarter. Over 3 fiscal years it compounded at +5.8% a year.
Context
- Total current liabilities amounted to 0.5% of total assets at the end of Q1 FY2026, up 0.3 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +166.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 544.07K USD
- Year-over-year change
- +158.7%
- 3-year CAGR
- +5.8%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 544.07K | +158.7% |
| FY2024 | 2024-12-31 | 210.3K | -58.7% |
| FY2023 | 2023-12-31 | 509.68K | +10.9% |
| FY2022 | 2022-12-31 | 459.39K | — |
Total Current Liabilities vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 total current liabilities of $861.09K is the 3rd highest of the 7 companies compared; the peer median is $296.23K.
- Its year-over-year change of +166.7% is the 3rd highest of 6, against a peer median of +64.1%.
- Total current liabilities amounts to 0.5% of total assets for TDAC, versus a peer median of 0.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
MACIMelar Acquisition Corp. I | Mar 2026 | $5.13M | +15528.2% | — | 2.9% |
| Mar 2026 | $1.13M | +684.4% | — | 0.5% | |
| Mar 2026 | $861.09K | +166.7% | +5.8% | 0.5% | |
| Mar 2026 | $380.03K | +4.5% | -57.0% | 0.2% | |
| Jun 2025 | $212.43K | — | — | 50.9% | |
| Mar 2026 | $138.74K | +9.2% | -84.0% | 0.1% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $127.12K | +64.1% | — | 0.1% |
| Peer median (excluding TDAC) | $296.23K | +64.1% | -70.5% | 0.3% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.